Endurant Capital Management’s Medicines Co MDCO Stock Holding History

Endurant Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-17,000	Closed	-$560K	–	84
2018 Q1	$560K	Sell	17,000 -24,200	-59%	-$756K	0.21%	64
2017 Q4	$1.13M	Buy	+41,200	New	+$1.27M	0.34%	57
2017 Q1	–	Sell	-27,300	Closed	-$927K	–	100
2016 Q4	$927K	Buy	27,300 +6,700	+33%	+$238K	0.38%	52
2016 Q3	$777K	Buy	+20,600	New	+$776K	0.29%	58

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Endurant Capital Management's MDCO Position: Q2 2018 in Review

Endurant Capital Management sold out of Medicines Co (MDCO) in Q2 2018, closing a stake of 17,000 shares — an estimated $560K sold.

Endurant Capital Management first reported a position in MDCO in Q3 2016 and held it in 4 quarters. The position peaked at $1.13M in Q4 2017. 188 funds tracked by Wall St. Rank hold MDCO as of Q2 2018.

Endurant Capital Management reported no remaining Medicines Co position as of Q2 2018 after selling out during the quarter.
Endurant Capital Management sold 17,000 Medicines Co shares in Q2 2018, an estimated $560K.
Endurant Capital Management first reported a position in Medicines Co in Q3 2016 and held it in 4 quarters.
Endurant Capital Management's Medicines Co position peaked at $1.13M in Q4 2017.
188 funds tracked by Wall St. Rank held Medicines Co as of Q2 2018.

Based on Endurant Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.